Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Megan Blanche Murray, D.P.H., M.D.

TitleProfessor of Global Health and Social Medicine
InstitutionHarvard Medical School
DepartmentGlobal Health and Social Medicine
AddressHarvard Medical School
4th Floor
641 Huntington Ave
Boston MA 02115
Phone617/432-2781
Fax617/566-7805
Other Positions
TitleDirector of Research, Global Health & Social Medicine
InstitutionHarvard Medical School
DepartmentGlobal Health and Social Medicine

TitleAssociate Professor of Medicine
InstitutionBrigham and Women's Hospital
DepartmentMedicine
DivisionDivision of Global Health Equity

TitleProfessor in the Department of Epidemiology
InstitutionHarvard School of Public Health
DepartmentEpidemiology


 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Franke MF, Del Castillo H, Pereda Y, Lecca L, Cárdenas L, Fuertes J, Murray MB, Bayona J, Becerra MC. Modifiable factors associated with tuberculosis disease in children: a case-control study. Pediatr Infect Dis J. 2014 Jan; 33(1):109-11.
    View in: PubMed
  2. Kendall EA, Theron D, Franke MF, van Helden P, Victor TC, Murray MB, Warren RM, Jacobson KR. Alcohol, hospital discharge, and socioeconomic risk factors for default from multidrug resistant tuberculosis treatment in rural South Africa: a retrospective cohort study. PLoS One. 2013; 8(12):e83480.
    View in: PubMed
  3. Nebenzahl-Guimaraes H, Jacobson KR, Farhat MR, Murray MB. Systematic review of allelic exchange experiments aimed at identifying mutations that confer drug resistance in Mycobacterium tuberculosis. J Antimicrob Chemother. 2014 Feb; 69(2):331-42.
    View in: PubMed
  4. Ford CB, Shah RR, Maeda MK, Gagneux S, Murray MB, Cohen T, Johnston JC, Gardy J, Lipsitch M, Fortune SM. Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis. Nat Genet. 2013 Jun 9; 45(7):784-90.
    View in: PubMed
  5. Wirth KE, Tchetgen Tchetgen EJ, Silverman JG, Murray MB. How Does Sex Trafficking Increase the Risk of HIV Infection? An Observational Study From Southern India. Am J Epidemiol. 2013 Feb 1; 177(3):232-41.
    View in: PubMed
  6. Barter DM, Agboola SO, Murray MB, Bärnighausen T. Tuberculosis and poverty: the contribution of patient costs in sub-Saharan Africa - a systematic review. BMC Public Health. 2012; 12:980.
    View in: PubMed
  7. Jacobson KR, Theron D, Kendall EA, Franke MF, Barnard M, van Helden PD, Victor TC, Streicher EM, Murray MB, Warren RM. Implementation of GenoType MTBDRplus Reduces Time to Multidrug-Resistant Tuberculosis Therapy Initiation in South Africa. Clin Infect Dis. 2013 Feb; 56(4):503-8.
    View in: PubMed
  8. Jeon CY, Murray MB, Baker MA. Managing tuberculosis in patients with diabetes mellitus: why we care and what we know. Expert Rev Anti Infect Ther. 2012 Aug; 10(8):863-8.
    View in: PubMed
  9. Baker MA, Wilson D, Wallengren K, Sandgren A, Iartchouk O, Broodie N, Goonesekera SD, Sabeti PC, Murray MB. Polymorphisms in the gene that encodes the iron transport protein ferroportin 1 influence susceptibility to tuberculosis. J Infect Dis. 2012 Apr 1; 205(7):1043-7.
    View in: PubMed
  10. Baker MA, Lin HH, Chang HY, Murray MB. The risk of tuberculosis disease among persons with diabetes mellitus: a prospective cohort study. Clin Infect Dis. 2012 Mar; 54(6):818-25.
    View in: PubMed
  11. Franke MF, Murray MB, Muñoz M, Hernández-Díaz S, Sebastián JL, Atwood S, Caldas A, Bayona J, Shin SS. Food insufficiency is a risk factor for suboptimal antiretroviral therapy adherence among HIV-infected adults in urban Peru. AIDS Behav. 2011 Oct; 15(7):1483-9.
    View in: PubMed
  12. Harries AD, Lin Y, Satyanarayana S, Lönnroth K, Li L, Wilson N, Chauhan LS, Zachariah R, Baker MA, Jeon CY, Murray MB, Maher D, Bygbjerg IC, Enarson DA, Billo NE, Kapur A. The looming epidemic of diabetes-associated tuberculosis: learning lessons from HIV-associated tuberculosis. Int J Tuberc Lung Dis. 2011 Nov; 15(11):1436-44, i.
    View in: PubMed
  13. Jacobson KR, Theron D, Victor TC, Streicher EM, Warren RM, Murray MB. Treatment outcomes of isoniazid-resistant tuberculosis patients, Western Cape Province, South Africa. Clin Infect Dis. 2011 Aug; 53(4):369-72.
    View in: PubMed
  14. Jeon CY, Kang H, Kim M, Murray MB, Kim H, Cho EH, Park YK. Clustering of Mycobacterium tuberculosis strains from foreign-born patients in Korea. J Med Microbiol. 2011 Dec; 60(Pt 12):1835-40.
    View in: PubMed
  15. Baker MA, Harries AD, Jeon CY, Hart JE, Kapur A, Lönnroth K, Ottmani SE, Goonesekera SD, Murray MB. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med. 2011; 9:81.
    View in: PubMed
  16. Murray M, Oxlade O, Lin HH. Modeling social, environmental and biological determinants of tuberculosis. Int J Tuberc Lung Dis. 2011 Jun; 15 Suppl 2:S64-70.
    View in: PubMed
  17. Brooks-Pollock E, Becerra MC, Goldstein E, Cohen T, Murray MB. Epidemiologic inference from the distribution of tuberculosis cases in households in Lima, Peru. J Infect Dis. 2011 Jun 1; 203(11):1582-9.
    View in: PubMed
  18. Franke MF, Robins JM, Mugabo J, Kaigamba F, Cain LE, Fleming JG, Murray MB. Effectiveness of early antiretroviral therapy initiation to improve survival among HIV-infected adults with tuberculosis: a retrospective cohort study. PLoS Med. 2011 May; 8(5):e1001029.
    View in: PubMed
  19. Goldhaber-Fiebert JD, Jeon CY, Cohen T, Murray MB. Diabetes mellitus and tuberculosis in countries with high tuberculosis burdens: individual risks and social determinants. Int J Epidemiol. 2011 Apr; 40(2):417-28.
    View in: PubMed
  20. Jeon CY, Calver AD, Victor TC, Warren RM, Shin SS, Murray MB. Use of fluoroquinolone antibiotics leads to tuberculosis treatment delay in a South African gold mining community. Int J Tuberc Lung Dis. 2011 Jan; 15(1):77-83.
    View in: PubMed
  21. Ottmani SE, Murray MB, Jeon CY, Baker MA, Kapur A, Lönnroth K, Harries AD. Consultation meeting on tuberculosis and diabetes mellitus: meeting summary and recommendations. Int J Tuberc Lung Dis. 2010 Dec; 14(12):1513-7.
    View in: PubMed
  22. Jeon CY, Harries AD, Baker MA, Hart JE, Kapur A, Lönnroth K, Ottmani SE, Goonesekera S, Murray MB. Bi-directional screening for tuberculosis and diabetes: a systematic review. Trop Med Int Health. 2010 Nov; 15(11):1300-14.
    View in: PubMed
  23. Becerra MC, Appleton SC, Franke MF, Chalco K, Bayona J, Murray MB, Mitnick CD. Recurrence after treatment for pulmonary multidrug-resistant tuberculosis. Clin Infect Dis. 2010 Sep 15; 51(6):709-11.
    View in: PubMed
  24. Jacobson KR, Tierney DB, Jeon CY, Mitnick CD, Murray MB. Treatment outcomes among patients with extensively drug-resistant tuberculosis: systematic review and meta-analysis. Clin Infect Dis. 2010 Jul 1; 51(1):6-14.
    View in: PubMed
  25. Harries AD, Murray MB, Jeon CY, Ottmani SE, Lonnroth K, Barreto ML, Billo N, Brostrom R, Bygbjerg IC, Fisher-Hoch S, Mori T, Ramaiya K, Roglic G, Strandgaard H, Unwin N, Viswanathan V, Whiting D, Kapur A. Defining the research agenda to reduce the joint burden of disease from diabetes mellitus and tuberculosis. Trop Med Int Health. 2010 Jun; 15(6):659-63.
    View in: PubMed
  26. Sandgren A, Strong M, Muthukrishnan P, Weiner BK, Church GM, Murray MB. Tuberculosis drug resistance mutation database. PLoS Med. 2009 Feb 10; 6(2):e2.
    View in: PubMed
  27. Cohen T, Colijn C, Murray M. Modeling the effects of strain diversity and mechanisms of strain competition on the potential performance of new tuberculosis vaccines. Proc Natl Acad Sci U S A. 2008 Oct 21; 105(42):16302-7.
    View in: PubMed
  28. Lin HH, Murray M, Cohen T, Colijn C, Ezzati M. Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study. Lancet. 2008 Oct 25; 372(9648):1473-83.
    View in: PubMed
  29. Murray M, King G. The effects of International Monetary Fund loans on health outcomes. PLoS Med. 2008 Jul 22; 5(7):e162.
    View in: PubMed
  30. Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. 2008 Jul 15; 5(7):e152.
    View in: PubMed
  31. Franke MF, Appleton SC, Bayona J, Arteaga F, Palacios E, Llaro K, Shin SS, Becerra MC, Murray MB, Mitnick CD. Risk factors and mortality associated with default from multidrug-resistant tuberculosis treatment. Clin Infect Dis. 2008 Jun 15; 46(12):1844-51.
    View in: PubMed
  32. Cohen T, Colijn C, Finklea B, Wright A, Zignol M, Pym A, Murray M. Are survey-based estimates of the burden of drug resistant TB too low? Insight from a simulation study. PLoS One. 2008; 3(6):e2363.
    View in: PubMed
  33. Cohen T, Colijn C, Wright A, Zignol M, Pym A, Murray M. Challenges in estimating the total burden of drug-resistant tuberculosis. Am J Respir Crit Care Med. 2008 Jun 15; 177(12):1302-6.
    View in: PubMed
  34. Cohen T, Colijn C, Finklea B, Murray M. Exogenous re-infection and the dynamics of tuberculosis epidemics: local effects in a network model of transmission. J R Soc Interface. 2007 Jun 22; 4(14):523-31.
    View in: PubMed
  35. Colijn C, Cohen T, Murray M. Emergent heterogeneity in declining tuberculosis epidemics. J Theor Biol. 2007 Aug 21; 247(4):765-74.
    View in: PubMed
  36. Lin HH, Ezzati M, Murray M. Tobacco smoke, indoor air pollution and tuberculosis: a systematic review and meta-analysis. PLoS Med. 2007 Jan; 4(1):e20.
    View in: PubMed
  37. Lipsitch M, Cohen T, Murray M, Levin BR. Antiviral resistance and the control of pandemic influenza. PLoS Med. 2007 Jan; 4(1):e15.
    View in: PubMed
  38. Mathew TA, Ovsyanikova TN, Shin SS, Gelmanova I, Balbuena DA, Atwood S, Peremitin GG, Strelis AK, Murray MB. Causes of death during tuberculosis treatment in Tomsk Oblast, Russia. Int J Tuberc Lung Dis. 2006 Aug; 10(8):857-63.
    View in: PubMed
  39. Korves CT, Goldie SJ, Murray MB. Blood screening for west nile virus: the cost-effectiveness of a real-time, trigger-based strategy. Clin Infect Dis. 2006 Aug 15; 43(4):490-3.
    View in: PubMed
  40. Resch SC, Salomon JA, Murray M, Weinstein MC. Cost-effectiveness of treating multidrug-resistant tuberculosis. PLoS Med. 2006 Jul; 3(7):e241.
    View in: PubMed
  41. Louw GE, Warren RM, Donald PR, Murray MB, Bosman M, Van Helden PD, Young DB, Victor TC. Frequency and implications of pyrazinamide resistance in managing previously treated tuberculosis patients. Int J Tuberc Lung Dis. 2006 Jul; 10(7):802-7.
    View in: PubMed
  42. Cohen T, Lipsitch M, Walensky RP, Murray M. Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populations. Proc Natl Acad Sci U S A. 2006 May 2; 103(18):7042-7.
    View in: PubMed
  43. Korves CT, Goldie SJ, Murray MB. Cost-effectiveness of alternative blood-screening strategies for West Nile Virus in the United States. PLoS Med. 2006 Feb; 3(2):e21.
    View in: PubMed
  44. Cohen T, Murray M. Incident tuberculosis among recent US immigrants and exogenous reinfection. Emerg Infect Dis. 2005 May; 11(5):725-8.
    View in: PubMed
  45. Becerra MC, Pachao-Torreblanca IF, Bayona J, Celi R, Shin SS, Kim JY, Farmer PE, Murray M. Expanding tuberculosis case detection by screening household contacts. Public Health Rep. 2005 May-Jun; 120(3):271-7.
    View in: PubMed
  46. Cohen T, Murray M. Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness. Nat Med. 2004 Oct; 10(10):1117-21.
    View in: PubMed
  47. Kudva IT, Griffin RW, Murray M, John M, Perna NT, Barrett TJ, Calderwood SB. Insertions, deletions, and single-nucleotide polymorphisms at rare restriction enzyme sites enhance discriminatory power of polymorphic amplified typing sequences, a novel strain typing system for Escherichia coli O157:H7. J Clin Microbiol. 2004 Jun; 42(6):2388-97.
    View in: PubMed
  48. Cohen T, Becerra MC, Murray MB. Isoniazid resistance and the future of drug-resistant tuberculosis. Microb Drug Resist. 2004; 10(4):280-5.
    View in: PubMed
  49. Alland D, Whittam TS, Murray MB, Cave MD, Hazbon MH, Dix K, Kokoris M, Duesterhoeft A, Eisen JA, Fraser CM, Fleischmann RD. Modeling bacterial evolution with comparative-genome-based marker systems: application to Mycobacterium tuberculosis evolution and pathogenesis. J Bacteriol. 2003 Jun; 185(11):3392-9.
    View in: PubMed
  50. Lipsitch M, Cohen T, Cooper B, Robins JM, Ma S, James L, Gopalakrishna G, Chew SK, Tan CC, Samore MH, Fisman D, Murray M. Transmission dynamics and control of severe acute respiratory syndrome. Science. 2003 Jun 20; 300(5627):1966-70.
    View in: PubMed
  51. Lipsitch M, Murray MB. Multiple equilibria: tuberculosis transmission require unrealistic assumptions. Theor Popul Biol. 2003 Mar; 63(2):169-70.
    View in: PubMed
  52. Brickner PW, Vincent RL, First M, Nardell E, Murray M, Kaufman W. The application of ultraviolet germicidal irradiation to control transmission of airborne disease: bioterrorism countermeasure. Public Health Rep. 2003 Mar-Apr; 118(2):99-114.
    View in: PubMed
  53. Cohen T, Sommers B, Murray M. The effect of drug resistance on the fitness of Mycobacterium tuberculosis. Lancet Infect Dis. 2003 Jan; 3(1):13-21.
    View in: PubMed
  54. Hughes AL, Friedman R, Murray M. Genomewide pattern of synonymous nucleotide substitution in two complete genomes of Mycobacterium tuberculosis. Emerg Infect Dis. 2002 Nov; 8(11):1342-6.
    View in: PubMed
  55. Murray MB. Molecular epidemiology and the dynamics of tuberculosis transmission among foreign-born people. CMAJ. 2002 Aug 20; 167(4):355-6.
    View in: PubMed
  56. Murray M. Sampling bias in the molecular epidemiology of tuberculosis. Emerg Infect Dis. 2002 Apr; 8(4):363-9.
    View in: PubMed
  57. Murray M, Alland D. Methodological problems in the molecular epidemiology of tuberculosis. Am J Epidemiol. 2002 Mar 15; 155(6):565-71.
    View in: PubMed
  58. Murray M. Determinants of cluster distribution in the molecular epidemiology of tuberculosis. Proc Natl Acad Sci U S A. 2002 Feb 5; 99(3):1538-43.
    View in: PubMed
  59. Murray M, Nardell E. Molecular epidemiology of tuberculosis: achievements and challenges to current knowledge. Bull World Health Organ. 2002; 80(6):477-82.
    View in: PubMed
  60. Murray M, Rasmussen Z. Measles outbreak in a northern Pakistani village: epidemiology and vaccine effectiveness. Am J Epidemiol. 2000 Apr 15; 151(8):811-9.
    View in: PubMed
  61. Murray MJ, Murray AB, Murray NJ, Murray MB, Murray CJ. Molluscum contagiosum and herpes simplex in Maasai pastoralists; refeeding activation of virus infection following famine? Trans R Soc Trop Med Hyg. 1980; 74(3):371-4.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu. SPH faculty should contact Justin Sayde (jsaydehsph.harvard.edu).
Murray's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_